Avaí Bio reports sustained Klotho production in laboratory study
AVAI•Avaí Bio said laboratory research showed encapsulated cells maintained long-term Klotho production and secretion. Further studies are needed to establish dosing, long-term safety and clinical efficacy.
1. Laboratory results
Avaí Bio announced publication of laboratory research on sustained Klotho delivery by Klothonova, its 50/50 joint venture with Austrianova. Results published in Frontiers in Aging showed that encapsulated cells maintained long-term Klotho production and secretion in laboratory testing. The Cell-in-a-Box approach targets sustained protein delivery for age-related diseases.
